91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
announces that 4D Pharma are working with 91黑料 for an upcoming trial with its lead live biotherapeutic MRx0518 in combination with Merck KGaA’s Bavencio. (a subcription is required to view this article)
-
In this podcast, Martin Lachs discusses how clinical trials have been the backbone of cancer research.
-
This article discusses .
-
Dr. Brian Huber outlines the role biomarkers play in guiding therapeutic strategies.
-
How data flows in cell therapy studies differ from other studies and strategies to manage the high volume of data in CGT trials is highlighted in this .
-
91黑料’s Tamie Joeckel and Brandon Fletcher take us through .
-
Dr. Brian Huber, VP Drug Development & Consulting, discusses the shift from histology-based to lesion-based trial design in precision medicine
-
Andreas Dreps and Martin Lachs discuss the recent advances in cancer research and why oncology clinical trials must make use of these developments to stay ahead of the curve
-
In this interview, Cindy Spittle talks about the women role models who provided inspiration in her career in honour of International Women's Day.
-
A by Lawrence Johnson and Cynthia Spittle discussing personalised medicine and how digital devices can improve treatment across a wide spectrum of conditions (pages 16-17).
